• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Drug Products
  • All Drug Products
  • To assess the efficacy of esomeprazole 20mg once daily in subjects who still had heartburn after receiving rabeprazole

Disease
heartburn
Drug Name
Nexium
Generic Name
Esomeprazole
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
IV
Start Date
Jan 18, 1971
Study Name
D961HL00002
Study Id
D961HL00002
ClinicalTrials.gov ID
NCT01397084
Recruiting Status
Closed
Protocol Status
Not Available
Report
Apr 27, 2012
  • D961HL00002.pdf (123 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013